Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Communication Comprehension in the Schizophrenic Spectrum

NCT03225027 is registered in ClinicalTrials.gov with Hôpital NOVO as lead sponsor.

NCT NCT03225027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03225027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Communication Comprehension in the Schizophrenic Spectrum
Lead sponsor
Hôpital NOVO
Phase
Not applicable
Overall status
Completed
Start date
November 15, 2016
Completion date
May 27, 2019
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia simple